WHY MEASURE NT-PROBNP SERIALLY IN CHRONIC HEART FAILURE? MECHANISTIC ASSOCIATIONS OF NATRIURETIC PEPTIDE SLOPE FOLLOWING INITIATION OF SACUBITRIL/VALSARTAN

被引：0
|
作者：
Mohebi, Reza [1 ]
Liu, Yuxi [1 ]
Myhre, Peder Langeland [1 ]
Felker, Michael [1 ]
Prescott, Margaret [1 ]
Pina, Ileana L. [1 ]
Butler, Javed [1 ]
Ward, Jonathan [1 ]
Solomon, Scott D. [1 ]
Januzzi, James L., Jr. [1 ]
机构：
[1] Harvard Med Univ, Massachusetts Gen Hosp, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 81卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1593-159
引用
收藏
页码：635 / 635
页数：1
相关论文
共 50 条
  • [31] N-terminal pro-brain natriuretic peptide (NT-proBNP) as screening test for early stage heart failure.
    Triepels, RH
    Busscher, S
    van der Burgh, PH
    Vermes, I
    CLINICAL CHEMISTRY, 2003, 49 (06) : A37 - A38
  • [32] Utility of NT-proBNP and B-Type Natriuretic Peptide in predicting 90 day mortality of hospitalized patients with congestive heart failure
    Beede, Jennifer
    Isakson, Susan R.
    Gardetto, Nancy J.
    Chiu, Albert
    Clopton, Paul
    Maisel, Alan S.
    CIRCULATION, 2006, 114 (18) : 620 - 621
  • [33] Performance characteristics of N terminal pro brain natriuretic peptide (NT-ProBNP) and BNP assays in the diagnosis of heart failure in community settings
    Hobbs, FDR
    Davis, RC
    Roalfe, AK
    Trawinski, J
    Davies, MK
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 147A - 147A
  • [34] N-terminal Pro B-Type Natriuretic Peptide (NT-proBNP), Troponin T, and Incident Heart Failure: The Chronic Kidney Disease Prognosis Consortium
    Bansal, Nisha
    Schneider, Markus P.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [35] An Analysis on Clinical Outcomes and Diuretic Requirements Following Initiation of Sacubitril/Valsartan in Patients with Chronic Heart Failure with Reduced Ejection Fraction
    Pierson, Natalie
    Abbas, Cheryl
    Reeves, Gordon
    JOURNAL OF CARDIAC FAILURE, 2018, 24 (08) : S31 - S31
  • [36] Only Large Reductions in Concentrations of Natriuretic Peptides (BNP and NT-proBNP) Are Associated with Improved Outcome in Ambulatory Patients with Chronic Heart Failure
    Miller, Wayne L.
    Hartman, Karen A.
    Grill, Diane E.
    Burnett, John C., Jr.
    Jaffe, Allan S.
    CLINICAL CHEMISTRY, 2009, 55 (01) : 78 - 84
  • [37] Natriuretic peptides and other biomarkers in chronic heart failure: From BNP, NT-proBNP, and MR-proANP to routine biochemical markers
    Lainscak, Mitja
    von Haehling, Stephan
    Anker, Stefan D.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 132 (03) : 303 - 311
  • [38] The effect of nesiritide on serum levels of B-natriuretic peptide (BNP) and N-terminal ProBNP (NT-proBNP) in patients admitted for decompensated congestive heart failure
    Fitzgerald, RL
    Cremo, R
    Chiu, A
    Clopton, P
    Bhalla, V
    Maisel, AS
    JOURNAL OF CARDIAC FAILURE, 2004, 10 (04) : S52 - S52
  • [39] Clinical Value of N-terminal Pro-brain Natriuretic Peptide (NT-proBNP) Levels in the Diagnosis of Heart Failure in Elderly Population
    Zhang, Minhui
    Ma, Naihua
    Zang, Tianxin
    Zhang, Zhengxiang
    Feng, Qian
    Shao, Ming
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2021, 128 : 71 - 72
  • [40] Myocardial tissue Doppler echocardiography and N-terminal B-type natriuretic peptide (NT-proBNP) in diastolic and systolic heart failure
    Fabian Knebel
    Stephan Eddicks
    Ingolf Schimke
    Michael Bierbaum
    Sebastian Schattke
    Mark Beling
    Vanessa Raab
    Gert Baumann
    Adrian C Borges
    Cardiovascular Ultrasound, 6
12345